Effects of serelaxin in subgroups of patients with acute heart failure: results from RELAX-AHF

AIM: Patients hospitalized for acute heart failure (AHF) differ with respect of many clinical characteristics which may influence their prognosis and response to treatment. We have assessed possible differences in the effects of serelaxin on dyspnoea relief, 60 Day outcomes and 180 Day mortality acr...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Metra, Marco, Ponikowski, Piotr, Cotter, Gad, Davison, Beth A., Felker, G. Michael, Filippatos, Gerasimos, Greenberg, Barry H., Hua, Tsushung A., Severin, Thomas, Unemori, Elaine, Voors, Adriaan A., Teerlink, John R.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2013
Gaiak:
Esc Fasttrack
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3800849/
https://ncbi.nlm.nih.gov/pubmed/23999454
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/eht371
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak